Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. OTC
  4. MTHRY

Market Cap: $7.41B

MI

M3, Inc.

MTHRY
OTC (Other OTC)USD
Invest in MTHRY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

$5.55
-$0.08(-1.42%)
At close: Nov 18, 08:46 EST

More on M3, Inc.

  • News & announcements
  • Financials

M3, Inc. at a Glance

  • Profitable, with a net margin of 12.8% over the last 12 months.

Open

$5.86

Prev. Close

$5.55

High

$5.86

Low

$5.78

Key Statistics

52-Week Range28% of range
Low $3.97High $8.84
Market Cap
$7.41B
P/E Ratio
26.21x
EPS (TTM)
$34.78
Revenue (TTM)
$361.22B
Dividend Yield
1.22%
Price / Book
2.97x
Beta
0.47
Avg. Volume
126.06K

Company Profile

M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry. Its operations are segmented into five key areas: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. M3 manages several specialized online platforms, including m3.com, an exclusive information portal for healthcare professionals; MR-kun, which ensures member doctors receive ongoing updates via the m3com platform; QOL-kun, offering non-medical life support; and AskDoctors, where certified physicians address public health inquiries from the general public. Internationally, it operates MDLinx for U.S. medical professionals and Doctorsnetuk, a U.K.-based site supporting pharmaceutical companies and providing drug information databases across France, Germany, and Spain. Furthermore, M3 offers dedicated career services for doctors and pharmacists through its m3com CAREER platform. Its diverse business portfolio extends to sales and marketing for pharmaceutical and medical device companies, as well as the development, sale, and maintenance of electronic medical records and equipment for healthcare facilities. M3 also conducts surveys for medical professionals, offers online sales and marketing assistance to pharmaceutical firms, provides management consulting to medical institutions, delivers home-visit nursing services, and specializes in human resource solutions for healthcare staff, alongside managing clinical trial facilities. Established in 2000, the company was initially named So-netM3, Inc., before rebranding to M3, Inc. in January 2010. Its headquarters are located in Tokyo, Japan.

CEOItaru Tanimura
SectorHealthcare
IndustryMedical - Healthcare Information Services
Employees17K
IPO DateJun 29, 2020
ExchangeOTC
Exchange NameOther OTC
CurrencyUSD
Headquarters & Contact
AddressAkasaka Intercity
City / State / ZIPTokyo, TY, 107-0052
CountryJapan
Phone

MTHRY Stock FAQ

What does M3, Inc. do?

M3, Inc. is a Japanese company that delivers a broad spectrum of internet-based services, predominantly catering to medical professionals and the broader healthcare industry.

Where is M3, Inc. stock listed?

M3, Inc. trades on the Other OTC under the ticker MTHRY, priced in USD.

What is M3, Inc.'s market cap?

M3, Inc. has a market capitalisation of $7.41B, based on its latest share price.

What is the P/E ratio of MTHRY?

MTHRY trades at 26.21 times its trailing 12-month earnings.

What is MTHRY's 52-week high and low?

Over the past 52 weeks MTHRY has traded between $3.97 and $8.84.

Does M3, Inc. pay a dividend?

Yes. M3, Inc.'s dividend yields 1.22% at the current share price.

Is M3, Inc. profitable?

Profitable, with a net margin of 12.8% over the last 12 months.

Who is the CEO of M3, Inc.?

Itaru Tanimura is the CEO of M3, Inc., which is headquartered in Tokyo.

Shares trade 55% below a discounted cash flow (DCF) estimate of $11.96.
  • Low debt: borrowings are 9% of shareholders' equity.
  • Comfortable liquidity: 2.4x more short-term assets than short-term liabilities.
  • Pays a dividend yielding 1.22%.
  • Trading 28% of the way between its 52-week low and high.
  • Generated automatically from reported financial data. General information only, not financial advice.

    Fundamentals Scorecard

    Each pillar is scored out of 5 from the latest reported data.

    • Valuation

      Fair · 3.0/5

      Price vs earnings, book value and discounted cash flow.

    • Profitability

      Strong · 4.5/5

      Return on equity and return on assets.

    • Financial Health

      Strong · 4.0/5

      Debt levels and Altman Z-Score bankruptcy risk.

    • Fundamental Trend

      Fair · 2.8/5

      Piotroski F-Score: 9 checks on profit, leverage and efficiency.

    See the full financial breakdown →
    81 3 6229 8900
    Websitehttps://corporate.m3.com